基于“异类相制”理论探讨清络通痹方中雷公藤减毒原理

俞志超; 冯哲; 周学平

doi:10.14148/j.issn.1672-0482.2023.0501

基于“异类相制”理论探讨清络通痹方中雷公藤减毒原理

doi: 10.14148/j.issn.1672-0482.2023.0501

俞志超^1,,
冯哲²,
周学平^2, ,

1.
南京中医药大学中医学院·中西医结合学院，江苏南京 210023
2.
南京中医药大学第一临床医学院，江苏南京 210023

基金项目:

国家自然科学基金面上项目 81973741

国家自然科学基金面上项目 81573869

详细信息

作者简介:
俞志超，男，讲师，E-mail：zcyu@njucm.edu.cn

通讯作者:
周学平，女，教授，博士生导师，主要从事中医内科风湿病研究，E-mail：zxp@njucm.edu.cn

中图分类号: R289
计量
- 文章访问数: 427
- HTML全文浏览量: 42
- PDF下载量: 41
- 被引次数: 0
出版历程
- 收稿日期: 2023-04-10
- 网络出版日期: 2023-06-12
- 发布日期: 2023-06-10

Exploring the Formulation Thinking of Qingluo Tongbi Formula and the Principle of Tripterygium Wilfordii Detoxification Based on "Heterogeneous Restriction" Theory

1.
School of Chinese Medicine, School of Integrated Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, China
2.
The First Clinical Medical School, Nanjing University of Chinese Medicine, Nanjing 210023, China

摘要

摘要: 中药复方配伍是有毒中药减毒存效或增效的主要方法。介绍了“异类相制”复方配伍减毒理论的背景、内容和要点，“异类相制”复方配伍减毒理论主要包括性味相制、异效相制、扶正制毒三部分内容, 并对清络通痹方中雷公藤配伍减毒的原理进行了解析, 最后阐释了“异类相制”复方配伍减毒理论的科学内涵。
- 异类相制 /
- 配伍减毒 /
- 雷公藤 /
- 清络通痹方
Abstract: The compatibility of traditional Chinese medicine prescriptions is the main method for reducing toxicity, preserving efficacy, or enhancing the efficacy of toxic traditional Chinese medicine. This article introduces the background, content, and characteristics of "heterogeneous restriction" compound compatibility and detoxification theory, the "heterogeneous restriction" compound compatibility and detoxification theory mainly includes three parts: property and flavor restriction, heterologous effect restriction, and toxicity restriction by strengthening healthy qi. It also analyzes the principle of compatibility and detoxification of tripterygium wilfordii, and explains the scientific connotation of the "heterogeneous restriction" compound compatibility and detoxification theory.
- heterogeneous restriction /
- compatibility and detoxification /
- tripterygium wilfordii /
- Qingluo Tongbi Formula

HTML全文

参考文献(43)

[1]	周学平, 周玲玲, 王旭. 基于"异类相制"理论探讨中药复方的配伍减毒作用[J]. 中医杂志, 2013, 54(4): 271-273. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZYZ201304002.htm ZHOU XP, ZHOU LL, WANG X. Discussion on the compatibility and toxicity reduction effect of traditional Chinese medicine compound based on the theory of "heterogeneous phasesystem"[J]. J Tradit Chin Med, 2013, 54(4): 271-273. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZYZ201304002.htm
[2]	张静, 江莹, 王芳, 等. 基于"异类相制"理论探讨雷公藤肝毒性配伍减毒的作用[J]. 中草药, 2014, 45(18): 2711-2715. https://www.cnki.com.cn/Article/CJFDTOTAL-ZCYO201418034.htm ZHANG J, JIANG Y, WANG F, et al. Detoxicity effect of hepatotoxicity of Tripterygium wilfordii by compatibility mechanism based on "diversity restriction" theory[J]. Chin Tradit Herb Drugs, 2014, 45(18): 2711-2715. https://www.cnki.com.cn/Article/CJFDTOTAL-ZCYO201418034.htm
[3]	张娜, 赵良友, 刘永武, 等. 基于"异类相制"的马钱子复方配伍减毒的代谢组学研究[J]. 中医药学报, 2020, 48(7): 8-16. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYXB202007003.htm ZHANG N, ZHAO LY, LIU YW, et al. Metabolomics of Strychnos about formulation detoxicity effect based on " heterogeneous restriction" theory[J]. Acta Chin Med Pharmacol, 2020, 48(7): 8-16. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYXB202007003.htm
[4]	党娟丽, 郭东艳, 韦焕丽, 等. 不同配伍对芍药甘草附子汤中苯甲酰类乌头碱含量变化的影响[J]. 中南药学, 2017, 15(9): 1197-1200. https://www.cnki.com.cn/Article/CJFDTOTAL-ZNYX201709004.htm DANG JL, GUO DY, WEI HL, et al. Effect of different compatibilities on the content of benzoyl aconitine in Peony and licorice aconite decoction[J]. Central South Pharmacy, 2017, 15(9): 1197-1200. https://www.cnki.com.cn/Article/CJFDTOTAL-ZNYX201709004.htm
[5]	文敏, 姜山, 鞠爱霞, 等. 基于CYP450酶的大黄附子汤复方配伍规律研究[J]. 中国药学杂志, 2019, 54(22): 1846-1852. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGYX201922005.htm WEN M, JIANG S, JU AX, et al. Compound compatibility law of Rhubarb and Aconite Decoction based on CYP450 enzymes[J]. Chin Pharm J, 2019, 54(22): 1846-1852. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGYX201922005.htm
[6]	栾英杰, 侯万升. 《神农本草经》合注[M]. 北京: 人民军医出版社, 2010: 288. LUAN YJ, HOU WS. Annotations to the Sheng Nong's Herbal Classic[M]. Beijing: People's health publishing house, 2010: 288.
[7]	张冰. 中药不良反应与警戒概论[M]. 3版. 北京: 中国中医药出版社, 2017: 9. ZHANG B. Introduction to Adverse Reactions and Cautions of Traditional Chinese Medicine[M]. 3rd ed. Beijing: China traditional Chinese medicine publishing house, 2017: 9.
[8]	任应秋. 金匮要略语译[M]. 北京: 中国中医药出版社, 2019: 208. REN YQ. Translation of Synopsis of the Golden Chamber[M]. Beijing: China traditional Chinese medicine publishing house, 2019: 208.
[9]	周学平, 周玲玲, 朱华旭, 等. 从物质-代谢-毒性关联视角多维度解析雷公藤复方配伍"异类相制"减轻肝损伤机制[J]. 南京中医药大学学报, 2020, 36(6): 795-798. http://xb.njucm.edu.cn/article/id/zr20200604 ZHOU XP, ZHOU LL, ZHU HX, et al. Multi-dimensional analysis of the mechanism of Tripterygium Wilfordii Hook. f. compound prescription based on "heterogeneous restriction" in reducing hepatotoxicity from the perspective of substance-metabolism-toxicity correlation[J]. J Nanjing Univ Tradit Chin Med, 2020, 36 (6): 795-798. http://xb.njucm.edu.cn/article/id/zr20200604
[10]	丹波元简. 素问识[M]. 北京: 中医古籍出版社, 2017: 88. TAMBA YJ. Understanding Basic Questions[M]. Beijing: Traditional Chinese medicine classics press, 2017: 88.
[11]	冯哲, 周学平. 中药性味相制配伍减毒的方法探要[J]. 中华中医药杂志, 2013, 28 (3): 595-598. https://www.cnki.com.cn/Article/CJFDTOTAL-BXYY201303005.htm FENG Z, ZHOU XP. Exploration of the essentials for reducing medicine toxicity in the compatibility of prescriptions depending on the mutual restraint relations of the nature and flavor of drugs[J]. Chin J Tradit Chin Med, 2013, 28 (3): 595-598. https://www.cnki.com.cn/Article/CJFDTOTAL-BXYY201303005.htm
[12]	吴谦. 医宗金鉴[M]. 北京: 中国医药科技出版社, 2017: 25. WU Q. Golden Mirror of the Medical Tradition[M]. Beijing: The medicine science and technology press of China, 2017: 25.
[13]	王坦. 临床方剂学[M]. 济南: 山东科学技术出版社, 2019: 8. WANG T. Clinical Prescriptions[M]. Jinan: Shandong science and technology press, 2019: 8.
[14]	黄诗雄, 张莹, 杨兰兰. 常用肝毒性中药及其配伍减毒研究进展[J]. 西部中医药, 2019, 32 (10): 154-157. https://www.cnki.com.cn/Article/CJFDTOTAL-GSZY201910049.htm HUANG SX, ZHANG Y, YANG LL. Research progress on frequently-used hepatotoxic herbs, compatibility and attenuation[J]. West J Tradit Chin Med, 2019, 32 (10): 154-157. https://www.cnki.com.cn/Article/CJFDTOTAL-GSZY201910049.htm
[15]	李今庸. 黄帝内经研究新法[M]. 武汉: 湖北科学技术出版社, 2018: 312. LI JY. A New Method for Studying the Yellow Emperor's Inner Classic[M]. Wuhan: Hubei science and technology press, 2018: 312.
[16]	潘桂娟. 中医历代名家学术研究丛书: 张子和[M]. 北京: 中国中医药出版社, 2017: 58. PAN GJ. Academic Research Series of Famous Masters in Traditional Chinese Medicine[M]. Beijing: China traditional Chinese medicine publishing house, 2017: 58.
[17]	俞尚德. 中药不良反应防治[M]. 南宁: 广西科学技术出版社, 2001: 51. YU SD. Prevention and treatment of adverse reactions of traditional Chinese medicine[M]. Nanning: Guangxi science and technology press, 2001: 51.
[18]	王庆其. 内经选读[M]. 北京: 人民卫生出版社, 2006: 78. WANG QQ. Selected Readings of the Inner Classic[M]. Beijing: People's health publishing house, 2006: 78.
[19]	周学平, 周仲瑛. 类风湿性关节炎阴虚络热证辨治初探[J]. 中国中医基础医学杂志, 2004, 10(1): 53-56. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYJC200401017.htm ZHOU XP, ZHOU ZY. Preliminary study on syndrome differentiation and treatment of rheumatoid arthritis with Yin deficiency and collateral heat syndrome[J]. China J Basic Med Tradit Chin Med, 2004, 10(1): 53-56. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYJC200401017.htm
[20]	黄艳, 王明艳, 周玲玲, 等. 基因芯片技术研究清络痛痹颗粒对类风湿关节炎患者成纤维样滑膜细胞基因表达的影响[J]. 中华中医药杂志, 2014, 29(9): 2945-2948. https://www.cnki.com.cn/Article/CJFDTOTAL-BXYY201409071.htm HUANG Y, WANG MY, ZHOU LL, et al. Study on the effects of Qingluo Tongbi Granules on gene expression pattern of FLS in patients with rheumatoid arthritis by gene chip technique[J]. China J Tradit Chin Med Pharm, 2014, 29(9): 2945-2948. https://www.cnki.com.cn/Article/CJFDTOTAL-BXYY201409071.htm
[21]	梁卫. 清络通痹颗粒治疗类风湿关节炎的机理研究[D]. 南京: 南京中医药大学, 2005. LIANG W. Mechanism of Qingluo Tongbi Granule in treating rheumatoid arthritis[D]. Nanjing: Nanjing University of Chinese Medicine, 2005.
[22]	周玲玲, 柳璋璞, 周聪, 等. 清络通痹颗粒通过MAPKs信号通路干预共培养诱生的破骨样细胞的分化[J]. 中国免疫学杂志, 2013, 29(12): 1235-1239. https://www.cnki.com.cn/Article/CJFDTOTAL-ZMXZ201312002.htm ZHOU LL, LIU ZP, ZHOU C, et al. Influence of MAPK pathways on co-cultured osteoclasts differentiation and effects of Qingluotongbi Granule on MAPK expressions[J]. Chin J Immunol, 2013, 29 (12): 1235-1239. https://www.cnki.com.cn/Article/CJFDTOTAL-ZMXZ201312002.htm
[23]	杨娟. 清络通痹颗粒干预类风湿关节炎骨质破坏的机制研究[D]. 南京: 南京中医药大学, 2010. YANG J. Mechanisms of Qingluo Tongbi Granule intervention on bone destruction of rheumatoid arthritis[D]. Nanjing: Nanjing University of Chinese Medicine, 2010.
[24]	周学平, 周玲玲, 陈晨, 等. 清络通痹颗粒干预类风湿关节炎破骨细胞分化相关因子分泌的研究[J]. 中国免疫学杂志, 2014, 30(2): 202-204, 208. https://www.cnki.com.cn/Article/CJFDTOTAL-ZMXZ201402017.htm ZHOU XP, ZHOU LL, CHEN C, et al. Effects of Qingluo Tongbi Granule on secretion of osteoclast differentiation related factors in rheumatoid arthritis[J]. Chin J Immunol, 2014, 30(2): 202-204, 208. https://www.cnki.com.cn/Article/CJFDTOTAL-ZMXZ201402017.htm
[25]	周学平, 周仲瑛, 金妙文, 等. 清络通痹颗粒治疗类风湿性关节炎阴虚络热证63例临床研究[J]. 中医杂志, 2003, 44(3): 191-193. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZYZ200303023.htm ZHOU XP, ZHOU ZY, JING MW, et al. Clinical study on the treatment of 63 cases of rheumatoid arthritis with Yin deficiency and collateral heat syndrome with Qingluo Tongbi Granules[J]. J Tradit Chin Med, 2003, 44(3): 191-193. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZYZ200303023.htm
[26]	方春阳. 中国医药大成[M]. 长春: 吉林科学技术出版社, 1994: 647. FANG CY. Chinese Medicine Collection[M]. Changchun: Jilin science & technology press, 1994: 647.
[27]	李亚娟, 费里德·穆拉德, 卞卡. 滋阴清热药在维护健康血管内环境中的作用[J]. 上海中医药大学学报, 2007, 21(5): 80-83. https://www.cnki.com.cn/Article/CJFDTOTAL-SHZD200705026.htm LI YJ, MURAD F, BIAN K. Effect of herbs for nourishing Yin and clearing heat on vascular homeostasis[J]. Acta Univ Tradit Med Sin Pharmacol Shanghai, 2007, 21(5): 80-83. https://www.cnki.com.cn/Article/CJFDTOTAL-SHZD200705026.htm
[28]	乔羽. OSAHS合并动脉粥样硬化证型及益气活血药对白色脂肪棕色化机制的研究[D]. 北京: 中国中医科学院, 2019. QIAO Y. TCM syndrome distribution of OSAHS combined with atherosclerosis and mechanism of its white adipose tissue browning by yiqihuoxue formula[D]. Beijing: China Academy of Chinese Medical Sciences, 2019.
[29]	陈琪, 孙满强, 李世超, 等. 地黄水提物对雷公藤甲素致肝损伤的减毒作用及抗氧化机制[J]. 上海中医药大学学报, 2020, 34(4): 47-52, 108. https://www.cnki.com.cn/Article/CJFDTOTAL-SHZD202004010.htm CHEN Q, SUN MQ, LI SC, et al. Attenuation effects and antioxidant mechanisms of aqueous extract of Rehmanniae Radix on triptolide-induced liver injury[J]. Acad J Shanghai Univ Tradit Chin Med, 2020, 34(4): 47-52, 108. https://www.cnki.com.cn/Article/CJFDTOTAL-SHZD202004010.htm
[30]	XIE T, ZHOU XP, WANG SC, et al. Development and application of a comprehensive lipidomic analysis to investigate Tripterygium wilfordii-induced liver injury[J]. Anal Bioanal Chem, 2016, 408(16): 4341-4355.
[31]	刘庆华, 刘彦辰. 实用植物本草[M]. 天津: 天津科学技术出版社, 1998: 331. LIU QH, LIU YC. Practical Plant Herb[M]. Tianjin: Tianjin science and technology press, 1998: 331.
[32]	陈继红, 劳志英, 何东仪. 雷公藤多苷联合青藤碱治疗类风湿关节炎49例[J]. 上海中医药杂志, 2011, 45(10): 64-65. https://www.cnki.com.cn/Article/CJFDTOTAL-SHZZ201110029.htm CHEN JH, LAO ZY, HE DY. Treatment of 49 cases of rheumatoid arthritis by tripterygium glycoside and sinomenine[J]. Shanghai J Tradit Chin Med, 2011, 45(10): 64-65. https://www.cnki.com.cn/Article/CJFDTOTAL-SHZZ201110029.htm
[33]	刘益杰, 朱鸿飞, 冯伟, 等. 染料木素和青藤碱对佐剂型关节炎大鼠血清IL-17、Tracp的影响[J]. 上海中医药大学学报, 2011, 25(1): 46-48. https://www.cnki.com.cn/Article/CJFDTOTAL-SHZD201101017.htm LIU YJ, ZHU HF, FENG W, et al. Effects of genistein andsinomenine on serum IL-17 and tracp in adjuvant-induced arthritis rats[J]. Acta Univ Tradit Med Sin Pharmacol Shanghai, 2011, 25(1): 46-48. https://www.cnki.com.cn/Article/CJFDTOTAL-SHZD201101017.htm
[34]	朱燕飞, 楼英. 甘味药作用特点分析[J]. 上海中医药杂志, 2011, 45(4): 18-19. https://www.cnki.com.cn/Article/CJFDTOTAL-SHZZ201104009.htm ZHU YF, LOU Y. Analysis of action features of sweet-taste herbs[J]. Shanghai J Tradit Chin Med, 2011, 45(4): 18-19. https://www.cnki.com.cn/Article/CJFDTOTAL-SHZZ201104009.htm
[35]	ZHANG BY, ZHANG QC, LIU MZ, et al. Increased involvement of Panaxnotoginseng in the mechanism of decreased hepatotoxicity induced by Tripterygium wilfordii in rats[J]. J Ethnopharmacol, 2016, 185: 243-254.
[36]	单书健. 古今名医临证金鉴: 痹证(上)[M]. 北京: 中国医药科技出版社, 2011: 147. SHAN SJ. Ancient and Modern Famous Doctors' Medical Certificate: Arthralgia Syndrome (Volume Ⅰ)[M]. Beijing: China medical science and technology press, 2011: 147.
[37]	尤在泾. 金匮要略心典[M]. 北京: 中国医药科技出版社, 2014: 80. YOU ZJ. Personal Standards for the "Essentials from the Golden Cabinet"[M]. Beijing: China medical science and technology press, 2014: 80.
[38]	陈修园. 陈修园医书全集: 下[M]. 北京: 中医古籍出版社, 2017: 1149. CHEN XY. Complete Collection of Chen Xiuyuan's Medical Books: Volume Ⅱ[M]. Beijing: China ancient books publishing house, 2017: 1149.
[39]	张垚, 杨继, 王强. 论蝉蜕、地龙、僵蚕在慢性气道疾病中的应用[J]. 湖南中医杂志, 2019, 35(8): 155-157. https://www.cnki.com.cn/Article/CJFDTOTAL-HNZO201908075.htm ZHANG Y, YANG J, WANG Q. Application of cicada slough, earthworm and Bombyx batryticatus in chronic airway diseases[J]. Hunan J Tradit Chin Med, 2019, 35(8): 155-157. https://www.cnki.com.cn/Article/CJFDTOTAL-HNZO201908075.htm
[40]	王禄. 浅议虫类药在咳喘病中的应用[J]. 河南中医, 2016, 36(7): 1284-1286. https://www.cnki.com.cn/Article/CJFDTOTAL-HNZY201607065.htm WANG L. Brief analysis of the application of worm drugs to cough and asthma[J]. Henan Tradit Chin Med, 2016, 36(7): 1284-1286. https://www.cnki.com.cn/Article/CJFDTOTAL-HNZY201607065.htm
[41]	LI M, WANG J, FU L, et al. Network pharmacology-based prediction and verification of Qingluo Tongbi formula to reduce liver toxicity of Tripterygium wilfordii via UGT2B7 in endoplasmic reticulum[J]. Med Sci Monit, 2020, 26: e920376.
[42]	FU L, ZHOU LL, GENG S, et al. Catalpol coordinately regulates phase Ⅰ and Ⅱ detoxification enzymes of Triptolide through CAR and NRF2 pathways to reduce Triptolide-induced hepatotoxicity[J]. Biomed Pharmacother, 2020, 129: 110379.
[43]	李其忠. 中医基础理论精解[M]. 上海: 上海中医药大学出版社, 2006: 263. LI QZ. Refined Explanation of Basic Theory of Traditional Chinese Medicine[M]. Shanghai: Shanghai university of traditional Chinese medicine press, 2006: 263.